Addison disease: early detection and treatment principles.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic search or original human trial data.
What was done
This clinical review summarizes the epidemiology, pathophysiology, diagnostic evaluation, and treatment principles for primary adrenal insufficiency (Addison disease).
What was found
The abstract reports an estimated prevalence of one in 20,000 persons in the United States and Western Europe, and notes that up to 50% of patients develop another autoimmune disorder in their lifetime. No primary experimental numbers or effect sizes are provided.
Why it matters
The paper outlines early identification strategies to prevent progression to life-threatening adrenal crisis and summarizes core management rules, including stress-dose steroids during physiological illness or surgery.
Limits
The paper is an unsystematic narrative review with no original empirical data, no comparator groups, and no quantitative diagnostic or therapeutic efficacy metrics reported in the abstract.
Cited by
- context Addison's disease is an autoimmune condition characterized by low cortisol, weight loss, skin hyperpigmentation, poor immune function, and inability to retain sodium.